I. Brigida

发表

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature

C. Doglioni, M. Roncarolo, A. Aiuti, 2018, Front. Immunol..

Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency

A. Aiuti, F. Ferrua, I. Brigida, 2010, Current opinion in allergy and clinical immunology.

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Alessandro Aiuti, Maria Grazia Valsecchi, Stefania Galimberti, 2009, The New England journal of medicine.

Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID

M. Roncarolo, A. Aiuti, R. Chiesa, 2009, Immunologic research.

Scientific category: Immunobiology HIV-1 envelope-dependent restriction of CXCR4-using viruses in children but not adult untransformed CD4 T lymphocyte lines Running head: R5 but not X4 HIV-1 replicates in children T cells on feeder cells

A. Kajaste-Rudnitski, E. Vicenzi, A. Mariani, 2012 .

B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.

M. van der Burg, J. V. van Dongen, J. Puck, 2014, The Journal of allergy and clinical immunology.

Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency

A. Aiuti, I. Brigida, N. Carriglio, 2012, Front. Immun..

Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study

L. Biasco, S. Galimberti, M. Valsecchi, 2019, The Lancet. Haematology.

A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation

D. Lazarević, C. Lanzani, Davide Cittaro, 2016, Journal of Allergy and Clinical Immunology.

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome

M. van der Burg, L. Naldini, M. C. Castiello, 2015, The Journal of allergy and clinical immunology.

In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.

C. Cancrini, A. Aiuti, B. Cassani, 2011, The Journal of allergy and clinical immunology.

Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID

C. Cancrini, M. Roncarolo, A. Aiuti, 2010, Haematologica.

Immune deficiencies , infection , and systemic immune disorders B-cell reconstitution after lentiviral vector – mediated gene therapy in patients with Wiskott-Aldrich syndrome

L. Naldini, M. Roncarolo, M. C. Castiello, 2022 .

First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia

C. Cancrini, M. Chiriacò, A. Aiuti, 2019, Front. Immunol..

Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity

C. Doglioni, S. C. Mannurita, E. Gambineri, 2013, Clinical immunology.

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

A. Del Maschio, C. Bordignon, A. Aiuti, 2012, Blood.

Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.

M. Roncarolo, P. L. Poliani, F. Sanvito, 2012, Blood.

Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency.

A. Aiuti, H. Dadi, C. Roifman, 2011, The Journal of allergy and clinical immunology.

The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment.

E. Stupka, D. Lazarević, P. Palma, 2017, Clinical immunology.

Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies

D. Lazarević, C. Pignata, S. Giliani, 2019, Front. Immunol..

Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency

F. Locatelli, A. Aiuti, M. Bernardo, 2017, Scientific Reports.

ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation

M. Degano, A. Aiuti, F. Barzaghi, 2019, Front. Immunol..

Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency

G. Giardino, E. Cirillo, V. Lougaris, 2021, bioRxiv.

Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy.

E. Meffre, A. Aiuti, H. Morbach, 2012, The Journal of clinical investigation.

A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency.

Ivan K. Chinn, J. Lupski, U. Pannicke, 2019, The Journal of allergy and clinical immunology.

Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency

A. Mortellaro, A. Aiuti, M. Ponzoni, 2022, Frontiers in Immunology.

Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell

Luca Biasco, Alessandro Aiuti, Christof von Kalle, 2011, EMBO molecular medicine.

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

Ivan K. Chinn, J. Lupski, R. Gibbs, 2019, The Journal of experimental medicine.

T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency.

J. Casanova, L. Notarangelo, J. Franco, 2018, Blood.

Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency

F. Locatelli, A. Aiuti, M. Bernardo, 2017, Scientific Reports.

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

J. Puck, I. Tezcan, M. Roncarolo, 2016, Blood.

Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies

D. Lazarević, C. Pignata, S. Giliani, 2019, Front. Immunol..

Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency.

L. Naldini, A. Pession, A. Mortellaro, 2021, Blood advances.

HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.

A. Kajaste-Rudnitski, E. Vicenzi, A. Aiuti, 2012, Blood.

Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency

S. Galimberti, M. Roncarolo, M. Eibl, 2009 .

Next-Generation Sequencing Reveals A JAGN1 Mutation in a Syndromic Child With Intermittent Neutropenia

P. Palma, C. Cancrini, M. Chiriacò, 2019, Journal of pediatric hematology/oncology.

Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection

A. Jenkner, E. Stupka, D. Lazarević, 2016, Journal of Clinical Immunology.

Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency

A. Aiuti, F. Ferrua, I. Brigida, 2010, Current opinion in allergy and clinical immunology.